glp-1 pediatric Oral Semaglutide Shows Promise in Adolescents with Type 2 Diabetes GLP-1 receptor agonists 'have changed

novel therapies like IL-15 inhibitors block the source of immune attacks by eliminating pathogenic T cells

#PharmaIntelligence #GenericDrugs #RegulatoryAffairs #PharmacodiaGlobal #ChinaPharma #DrugDevelopment To view or add a comment, sign in Canada Adopts ICH M13A Guideline for Some Modified Release (MR) Products Based on: Health Canada's official notice on ICH M13A implementation Link to Notice What is ICH M13A

The items below reflect a mix of what the research suggests and what patients commonly describe in clinical practice

Dietary L-Carnitine Affects Leukocyte Count and Function in Dairy Cows Around Parturition [PMID: 35370999] Laboratory literature summary: Dietary L-Carnitine Affects Leukocyte Count and Function in Dairy Cows Around Parturition

The long-acting analoguesparticularly semaglutide and tirzepatideachieve the greatest reductions in glycated hemoglobin and body weight, while liraglutide and dulaglutide show moderate but clinically relevant benefits

Presented for research literature review only Arafa HM et al